Editorial
Published on 17 Oct 2022
Editorial: Ethics and COVID-19: The bioethics of a “job well done” in public health
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.996408
- 1,500 views
- 3 citations
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
362 articles
Articles
Systematic Review
Published on 12 Oct 2022
Design and analysis of umbrella trials: Where do we stand?
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.1037439
- 8,419 views
- 4 citations
Original Research
Published on 10 Oct 2022
Challenges related to data protection in clinical research before and during the COVID-19 pandemic: An exploratory study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.995689
- 4,654 views
- 6 citations
Review
Published on 10 Oct 2022
Do we miss rare adverse events induced by COVID-19 vaccination?
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.933914
- 11,344 views
- 9 citations
Original Research
Published on 27 Sep 2022
Rethinking informed consent in the time of COVID-19: An exploratory survey
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.995688
- 3,934 views
- 8 citations
Original Research
Published on 23 Sep 2022
Outcome-based reimbursement in Central-Eastern Europe and Middle-East
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.940886
- 3,395 views
- 7 citations
Original Research
Published on 23 Sep 2022
A nationwide survey on the management of the COVID-19 pandemic and respiratory disease in South Korea
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.965651
- 2,402 views
- 2 citations
Original Research
Published on 21 Sep 2022
On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.996903
- 3,753 views
- 16 citations
Editorial
Published on 20 Sep 2022
Editorial: Insights in Regulatory Science 2021
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.1033558
- 1,123 views
- 2 citations
Opinion
Published on 16 Sep 2022
The continuation of clinical trials in times of war: A need to develop ethics and situationally adaptive clinical research guidelines
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.966220
- 3,452 views
- 4 citations
Study Protocol
Published on 14 Sep 2022
Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome prediction
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.998972
- 1,362 views
- 1 citation
Original Research
Published on 09 Sep 2022
Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.975032
- 3,006 views
Perspective
Published on 25 Aug 2022
Data-driven integrated care pathways: Standardization of delivering patient-centered care
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.883874
- 3,649 views
- 5 citations
Original Research
Published on 23 Aug 2022
Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.893080
- 3,148 views
- 2 citations
Systematic Review
Published on 18 Aug 2022
Characterizing pharmacogenetic programs using the consolidated framework for implementation research: A structured scoping review
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.945352
- 4,020 views
- 12 citations
Review
Published on 12 Aug 2022
A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.968272
- 7,106 views
- 15 citations